Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8773530 | 0.97 | CYP2A6 (0.41) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL9625686 | 0.97 | CYP2A6 (0.41) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL7882217 | 0.85 | CYP1A2 (0.36) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL377159 | 0.83 | ALDH1A1 (0.37) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL29955866 | 0.83 | ALDH1A1 (0.37) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL11347627 | 0.81 | CYP1A2 (0.33) | CYP1A2ACHETSHRESR1 | |
| Hydrochloric Acid SCHEMBL11808601 | 0.81 | ALDH1A1 (0.35) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL11583476 | 0.79 | ALDH1A1 (0.36) | ALDH1A1TRPA1ATM | |
| SCHEMBL7224776 | 0.79 | GABRA1 (0.50) | CYP2A6CYP1A2ACHETSHRALDH1A1 | |
| SCHEMBL29955843 | 0.79 | GABRA1 (0.41) | ALDH1A1ESR1TDP1CYP3A4GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751360-A | 1-Amide-1, 2-dihydro phthalazine compound and preparation method and application thereof | 河南警察学院 | 2025-04-04 | — | — | CN | claimed |
| CN-118978552-A | Cyclometalated Pt (II) complex and preparation method and application thereof | 杭州师范大学 | 2024-11-19 | — | — | CN | claimed |
| CN-116283678-A | Preparation method of C-fluoroalkyl substituted amidine compound and application of C-fluoroalkyl substituted amidine compound in resisting fungal diseases | 中国农业大学 | 2023-06-23 | — | — | CN | claimed |
| CN-114524852-B | Preparation method of temperature solvent double-response chiral platinum complex organosol-gel | 海南师范大学 | 2023-06-09 | — | — | CN | claimed |
| CN-114524852-A | Preparation method of temperature solvent double-response chiral platinum complex organic sol-gel | 海南师范大学 | 2022-05-24 | — | — | CN | claimed |
| CN-110483572-B | Trinuclear gold alkynyl urea complex with tetrahedral oxyanion recognition function and preparation method thereof | 广州钰芯传感科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-109776605-B | Synthesis method of glufosinate-ammonium | 浙江工业大学 | 2021-08-03 | — | — | CN | claimed |
| EP-3269724-B1 | MONONUCLEAR IRON COMPLEX AND ORGANIC SYNTHESIS REACTION USING SAME | UNIV KYUSHU NAT UNIV CORP (JP) | 2020-04-22 | — | — | EP | claimed |
| EP-3118205-B1 | MONONUCLEAR RUTHENIUM COMPLEX AND ORGANIC SYNTHESIS REACTION USING SAME | UNIV KYUSHU NAT UNIV CORP (JP) | 2020-04-22 | — | — | EP | claimed |
| US-20180198163-A1 | Non-aqueous electrolytes for lithium-ion batteries comprising an isocyanide | GOTION INC (US) | 2018-07-12 | — | — | US | claimed |
| EP-2306788-A1 | Iridium compounds and devices made therewith | E. I. du Pont de Nemours and Company (US) | 2011-04-06 | — | — | EP | claimed |
| WO-2010105363-A1 | CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME | YUDIN ANDREI (CA) | 2010-09-23 | — | — | WO | claimed |
| US-7129518-B2 | Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-10-31 | — | — | US | claimed |
| US-20040188673-A1 | Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2004-09-30 | — | — | US | claimed |
| US-20040108507-A1 | Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2004-06-10 | — | — | US | claimed |
| US-20040106007-A1 | Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | GRUSHIN VLADIMIR (US) | 2004-06-03 | — | — | US | claimed |
| US-20040094769-A1 | Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2004-05-20 | — | — | US | claimed |
| US-20040089867-A1 | Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2004-05-13 | — | — | US | claimed |
| WO-2003063555-A1 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS WIHT FLUORINATED PHENYLPYRIDINES, PHENYLPYRIMIDINES, AND PHENYLQUINOLINES AND DEVICES MADE WITH SUCH COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-07-31 | — | — | WO | claimed |
| US-20020190250-A1 | Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2002-12-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180198163-A1 | Non-aqueous electrolytes for lithium-ion batteries comprising an isocyanide | HCN3, HCN2, CCNL2 | CYP2A6 3702/4885CYP1A2 2916/4885ACHE 2571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.